Lenti-ONE VEGF165b

APPLICATIONS

  • Angiogenesis
  • Apoptosis, Oxidative Stress
  • CAR T-cells
  • CRISPR
  • Differentiation
  • Dominant Negative Mutants
  • Neurology, Ophthalmology
  • Optogenetics
  • Recombinases, Editors
  • Reporters and selection
  • RNA Interference

TRANSGENES

Lenti-ONE VEGF165b

Lenti-ONE VEGF165b carries the VEGF165b cDNA. It encodes the vascular endothelial growth factor 165b (sequence from human genome, AF430806.1, 606 pb). This protein is an antagonist of VEGF165a and inhibits angiogenesis process. It may be used in anti-angiogenesis experimental gene transfer assays.

Lenti-ONE VEGF165b

DESCRIPTION

VEGF165b SIGNALING PATHWAY IN ENDOTHELIAL CELLS

 

Lenti-ONE VEGF165b -

EXAMPLES OF APPLICATIONS

  • Use with flt1 promoter to target the expression in endothelial cells

  • Use in vitro or in vivo to inhibit angiogenesis

  • Use in vitro, in vivo to study cancer mechanisms

RESULTS

VEGF EXPRESSION IN VITRO USING NON-INTEGRATIVE LENTI-ONE

 
Lenti-ONE VEGF165b -

Transduction of 293T cells in vitro with non-integrative Lenti-ONE VEGF121, VEGF165 or VEGF165b (100ng p24) induces transgene expression and VEGF secretion in cell culture medium (measured by ELISA).

Results provided by GEG Tech R&D

Technologies

Application Areas

COMPANY

SOCIAL

Facebook-f Twitter Youtube Linkedin